Clinical Trial Update: Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of tolterodine ER in subjects with overactive bladder; study terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Tolterodine ER (tolterodine tartrate (extended-release))

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Overactive Bladder | Phase 4 | Status: TERMINATED | Results posted: 2013-09-24